HaleonHLN +0.97%70 Market Cap is $41,120 Mil as of Jun. 30, 2026. GuruFocus rates HLN with a GF Score™ of 70/100 and a GF Value™ of $9.63 (Fairly Valued). The stock has 3 warning signs investors should review. Among 1,020 Drug Manufacturers companies, Haleon ranks better than 97.84% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Haleon's share price for the quarter that ended in Dec. 2025 was $10.11. Haleon's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 4,453 Mil. Therefore, Haleon's market cap for the quarter that ended in Dec. 2025 was $45,016 Mil.
Haleon's quarterly market cap
increased
from Dec. 2024 ($43,186 Mil) to Jun. 2025 ($46,583 Mil) but then
declined
from Jun. 2025 ($46,583 Mil) to Dec. 2025 ($45,016 Mil).
Haleon's annual market cap
increased
from Dec. 2023 ($37,957 Mil) to Dec. 2024 ($43,186 Mil) and
increased
from Dec. 2024 ($43,186 Mil) to Dec. 2025 ($45,016 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Haleon's Enterprise Value for Today is $51,026 Mil.
Haleon (NYSE:HLN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Haleon Market Cap Related Terms
Haleon Market Cap Historical Data
* Premium members only.
The historical data trend for Haleon's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haleon Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haleon's Market Cap distribution charts can be found below:
* The bar in red indicates where Haleon's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Haleon's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haleon (HLN) has a Market Cap of $41,120 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Haleon and its competitors. According to the industry distribution chart, Haleon ranks #22 out of 1020 companies in the Drug Manufacturers industry, placing it in the top 2.2%.
Is Haleon's Market Cap too high?
Haleon's current Market Cap is $41,120 Mil. The Drug Manufacturers industry median Market Cap is 206.61. Haleon's value of $41,120 Mil is 19802.3% above this industry median. Based on the distribution chart, Haleon ranks #22 out of 1020 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Haleon has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Haleon's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Haleon ranks #22 out of 1020 companies for Market Cap. This places Haleon in the top 2% of its industry — outperforming the majority of peers. The industry median Market Cap is 206.61. Haleon's value of $41,120 Mil is 19802.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 206.61, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haleon's current Market Cap of $41,120 Mil is 19802.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Haleon and its competitors. For the Drug Manufacturers industry, the median Market Cap is 206.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haleon's current Market Cap is $41,120 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleon stock overvalued right now?
Based on GuruFocus' analysis, Haleon (HLN) is currently considered Fairly Valued. The stock's GF Value™ is $9.63, compared to a current price of $9.33 — trading 3.1% below its estimated fair value. The current Market Cap is $41,120 Mil and 19802.3% above the Drug Manufacturers industry median of 206.61. Haleon's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Haleon (HLN), the current Market Cap is $41,120 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Haleon (HLN) Overvalued in 2026?
Based on GuruFocus' analysis, Haleon stock appears to be undervalued.
The current stock price of $9.33 is trading 3.1% below its estimated GF Value™ of $9.63.
GuruFocus considers Haleon to be Fairly Valued.
Key valuation signals for HLN:
Market Cap: $41,120 Mil
GF Value™: $9.63 vs. price of $9.33 (3.1% below fair value)
Industry Position: 19802.3% above the Drug Manufacturers median (#22 of 1020)
No single metric tells the full story. See the HLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
70GF Score
Get the complete analysis for HLN
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HLN has been successfully added to your 
